M&G plc’s Exact Sciences EXAS Stock Holding History

M&G plc’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-198,968	Closed	-$10.9M	–	394
2025 Q3	$10.9M	Buy	198,968 +6,394	+3%	+$319K	0.06%	201
2025 Q2	$10.2M	Buy	+192,574	New	+$9.78M	0.06%	203

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

M&G plc's EXAS Position: Q4 2025 in Review

M&G plc sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 198,968 shares — an estimated $10.9M sold.

M&G plc first reported a position in EXAS in Q2 2025 and held it in 2 quarters. The position peaked at $10.9M in Q3 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

M&G plc reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
M&G plc sold 198,968 Exact Sciences shares in Q4 2025, an estimated $10.9M.
M&G plc first reported a position in Exact Sciences in Q2 2025 and held it in 2 quarters.
M&G plc's Exact Sciences position peaked at $10.9M in Q3 2025.
711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on M&G plc's 13F filing for Q4 2025, filed 12 Feb 2026.